UBS raised the firm’s price target on Corteva (CTVA) to $90 from $76 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva price target raised to $86 from $74 at BMO Capital
- Corteva’s Strong Growth Potential and Financial Resilience Earns Buy Rating with Raised Target Price
- Corteva price target raised to $75 from $70 at Barclays
- Corteva price target raised to $82 from $79 at Wells Fargo
- Food, agriculture leaders warn of MAHA’s overreach, WSJ reports